|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR1800018223 |
|
最近更新日期: Date of Last Refreshed on: |
2018-11-03 21:55:14 |
|
注册时间: Date of Registration: |
2018-09-05 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
中国耳聋基因筛查与诊断临床多中心研究 |
|
Public title: |
Multicenter study for screening and diagnosis of deafness genes in China |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
单基因病(耳聋)出生缺陷三级预防干预及临床示范 |
|
Scientific title: |
Clinical demonstration for three level prevention intervention of birth defect on monogenic disease (deafness) |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
袁永一 |
研究负责人: |
戴朴 |
|
Applicant: |
Yuan Yongyi |
Study leader: |
Dai Pu |
|
申请注册联系人电话: Applicant telephone: |
+86 13811502776 |
研究负责人电话:
Study leader's |
+86 13910213511 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
yyymzh@163.com |
研究负责人电子邮件: Study leader's E-mail: |
daipu301@vip.sina.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市海淀区复兴路28号 |
研究负责人通讯地址: |
北京市海淀区复兴路28号 |
|
Applicant address: |
28 Fuxing Road, Haidian District, Beijing, China |
Study leader's address: |
28 Fuxing Road, Haidian District, Beijing, China |
|
申请注册联系人邮政编码: Applicant postcode: |
100853 |
研究负责人邮政编码: Study leader's postcode: |
100853 |
|
申请人所在单位: |
中国人民解放军总医院 |
||
|
Applicant's institution: |
People Liberty Army General Hospital |
||
|
研究负责人所在单位: |
中国人民解放军总医院 |
||
|
Affiliation of the Leader: |
People Liberty Army General Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
S2018-088-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中国人民解放军总医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Chinese PLA General Hospital Research Ethics Committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2018-07-26 00:00:00 | ||
|
伦理委员会联系人: |
曹江 |
||
|
Contact Name of the ethic committee: |
Jiang Cao |
||
|
伦理委员会联系地址: |
北京市海淀区复兴路28号 |
||
|
Contact Address of the ethic committee: |
28 Fuxing Road, Haidian District, Beijing, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 010-66937166 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
中国人民解放军总医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Chinese PLA General Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市海淀区复兴路28号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
28 Fuxing Road, Haidian District, Beijing, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
北京迈基诺基因科技股份有限公司,北京希望组医学项目部,明码生物科技公司,博奥木华基因科技有限公司 |
||||||||||||||||||||||
|
Source(s) of funding: |
MyGenostics Inc.; GrandOmics Inc.; WuXi NextCODE Inc.; Capital Genomics Inc. |
||||||||||||||||||||||
|
研究疾病: |
遗传性耳聋 |
||||||||||||||||||||||
|
Target disease: |
genetic deafness |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
筛查 |
||||||||||||||||||||||
|
Study type: |
Screening |
||||||||||||||||||||||
|
研究所处阶段: |
诊断试验新技术临床试验 | ||||||||||||||||||||||
|
Study phase: |
Diagnostic New Technique Clincal Study |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
建立超过1万例高质量中国人群聋病基因数据库;绘制中国人群聋病基因变异全图谱、获得详细变异频率信息;规范检测流程/报告形式/报告解读/遗传咨询指导;形成聋病基因诊断临床实践联盟,建立疑难病例转诊会诊渠道;升级优化耳聋基因检测Panel;起草中国人群基因筛查与诊断临床指南。 |
||||||||||||||||||||||
|
Objectives of Study: |
Establish a high-quality genetic database of deafness in over 10,000 Chinese population; Map the complete genetic variation map of deafness in Chinese population and obtain detailed information on the frequency of mutation; Standardize the genetic test process / report form / report interpretation / genetic counseling guidance; Form a clinical practice Alliance for gene diagnosis of deafness, and establish a referral channel for difficult cases to upgrade; Optimization of deafness gene detection Panel; drafting of clinical guidelines for screening and diagnosis of Chinese populations. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1)先天性耳聋与迟发性耳聋患者及其家属 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Patients with congenital deafness and acquired deafness and their families; |
||||||||||||||||||||||
|
排除标准: |
(1)接受宣教后明确拒绝参加该项目的耳聋患者及其家属。 |
||||||||||||||||||||||
|
Exclusion criteria: |
(1) deaf patients and their families who refused to take part in the project after receiving education; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2018-09-01 00:00:00至 To 2022-08-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2018-10-01 00:00:00 至 To 2022-08-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
N/A |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
N/A |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
N/A |
|
Blinding: |
N/A |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2022-8-31 文章发表及邮箱询问 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
2022-8-31 study publish and requested by email |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
医院专人负责招募志愿者。项目过程中,患者的病例记录表的数据信息由各医院上传至多中心专用电子采集及管理系统,仅对参与研究单位开放,参与单位根据个人权限可进入进行数据查询和采集,各检测机构可以免费查询突变频率信息。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Persons in hospital are responsible for recruitment.The data information of the patient's CRF is uploaded from each hospital to the multi-center EDC system. It is only open to the participating research units. The participating units can enter the data inquiry and collection according to their personal authority, and each testing institution can inquire the mutation frequency information free of charge. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |